Rapid Micro Biosystems RPID Finance Lease, Right-of-Use Asset, Accumulated Amortization
Finance Lease, Right-of-Use Asset, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Rapid Micro Biosystems in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization.
The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapid Micro Biosystems's finance lease, right-of-use asset, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapid Micro Biosystems's finance lease, right-of-use asset, accumulated amortization?
- Rapid Micro Biosystems (RPID) reported finance lease, right-of-use asset, accumulated amortization of $267K in Q1 2026.
- How has Rapid Micro Biosystems's finance lease, right-of-use asset, accumulated amortization changed year-over-year?
- Rapid Micro Biosystems's finance lease, right-of-use asset, accumulated amortization increased by 16.1% year-over-year, from $230K to $267K.
- What is the long-term trend for Rapid Micro Biosystems's finance lease, right-of-use asset, accumulated amortization?
- Over 3 years (2022 to 2025), Rapid Micro Biosystems's finance lease, right-of-use asset, accumulated amortization has grown at a 55.0% compound annual growth rate (CAGR), from $69K to $257K.